SAE Media Group is proud to announce the return of their 3rd annual Peptides event to London in 2016!

In recent years, therapeutic peptides have been developed for the treatment of several diseases such as cancer, metabolic disorders, nervous system disorders and gastrointestinal disorders, among others. Further research has been done to develop a rich pipeline of novel peptides as a result of their efficacy treating a huge array of conditions, and the global peptide therapeutics market is expected to reach a value of US$23.7B by 2020*

SAE Media Group’s 3rd annual Peptides event provides the perfect platform to discuss the latest innovations and development in the peptides industry and explore a number of pressing issues such as the use of Cell Penetrating Peptides (CPP), the challenges involved with oral peptides and many more.




Hear from and meet with the key innovators in peptides research,
technologies and peptide therapeutics.

Discover collaborative solutions to peptides research and
technology challenges.

Discuss the latest innovations in peptide therapeutics, including utilising peptides in the clinic and
developments in peptide drug delivery systems

 • Head of Formulation
• Head of Peptide Chemistry
• Vice President, Peptides
• Vice President, Diabetes Protein and Peptide Chemistry
• Head of small molecules
• Formulation Scientist
• Global Head of Protein Engineering
• Lab Head of Early Development


Amcure; Bachem; Bicycle Therapeutics Limited; Bracco Imaging spa; CHEMI; Complix NV; CUNY-Hunter College; Ensemble Therapeutics; Ferring; GSK; Haemostatix Ltd; Ipsen Research Laboratories; Kings College London; Lonza Group Ltd; Med Immune; Medical University of Vienna; MedImmune; MHRA; Nexigen GmbH; Novo Nordisk; Pfizer; Pfizer Laboratories Ltd; Polypeptide Laboratories A B; Proxima Concepts Ltd; RAPID Pharmaceuticals; Selcia Ltd; Sunpharma; Tepnel Pharma Services; The University of Reading; UCB Pharma Limited; UCD School of Biomolecular and Biomedical Science Conway Institute University College Dublin; UCL Institute of Child Health; University; University College London Medical School; University Of Kent; University Of Southampton; University of Warwick; Whiteknights, Reading;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Lutz Jermutus

Lutz Jermutus, Senior Director, R&D, MedImmune

9:10 MEDI0382, a novel GLP1/glucagon co-agonist, as a promising therapeutic lead for the treatment of Type 2 diabetes and obesity

Lutz Jermutus

Lutz Jermutus, Senior Director, R&D, MedImmune

• Pre-clinical summary
• Clinical summary
• Mechanism of action studies

9:50 Purification of synthetic peptides by reversed phase chromatography

Mathias  Schaffrath

Mathias Schaffrath, Group Head Chromatography, Sanofi

• High throughput purifi cation by automation
• Mass triggered fractioning
• High quality and good recovery of the fi nal product

10:30 Morning Coffee

10:50 Peptide materials for the targeted and responsive delivery of therapeutics

11:30 Assessing immunogenicity in peptide development

Gary  Bembridge

Gary Bembridge, Director of Scientific Affairs Immunology, Abzena

• T-cell help as a risk factor in the development of
anti-drug antibodies
• Immunogenicity of peptides data updates
• Deimmunisation of naturally immunogenic non-human protein therapeutics

12:10 Networking Lunch

13:10 Live learning lab: Strategy for successful GMP peptide development, scale-up and manufacturing

Vincent Bille

Vincent Bille, Founder & Owner, Marble Pharma Consult, sprl

This interactive session will provide live insights related
to process and analytical development, management
of external supply operations. As well as demonstrate a life
cycle approach to manufacturing of peptide APIs including
process and regulatory dimensions.

• Challenges and decision points from early process
• Scaling-up: strategy and cost optimisation
• Validation and regulatory requirements
• Contract manufacturing and outsourcing management

14:10 Oral peptide delivery technology landscape

Leila Narimen Beniddir

Leila Narimen Beniddir, Study Manager/Scientist- Novel Drug Delivery Technologies, Ipsen

• Current status
• Particular considerations or oral peptide delivery
• Approaches and strategies for oral peptide delivery

14:50 Discovery of novel and potent orally stable peptide antagonists of the human IL-23 receptor and their pre-clinical POC in rat colitis models

Ashok Bhandari

Ashok Bhandari, VP, Chemistry, Protagonist Therapeutics

• Discovery of novel peptides antagonist for human IL-23
receptor that are
• Orally stable, GI restricted
• Selective
• Effi cacious in rat TNBS colitis model

15:30 Afternoon Tea

15:50 Using Cupid, a novel cell penetrating peptide, to carry GFP into cells

Jonathan  Ryves

Jonathan Ryves, Director, Cupid Peptides

• Advances in Cupid CPP technology
• Applications in stem cell research
• Looking to the future

16:30 Design of the theranostic CXCR4 ligand Pentixafor and its application in man

Oliver Demmer

Oliver Demmer, Innovation Consultant, Innovation Centre Denmark, Ministry Of Foreign Affairs

• Design of Pentixafor: N-methylated, cyclic peptides,
dimers and peptoids
• Optimisation of N-methylation/alkylation procedures
and other peptide modifi cations
• Effi cient on-resin strategies for the synthesis of branched
and modifi ed peptides
• PET imaging in man for cancer diagnosis using Pentixafor

17:10 Chairman’s Closing Remarks and Close of Day One

Lutz Jermutus

Lutz Jermutus, Senior Director, R&D, MedImmune

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Dan Teufel

Dan Teufel, Head of Chemistry, Bicycle Therapeutics Limited

9:10 New synthetic anti tuberculosis cyclohexylgriselimycin, more than 50 years after the isolation of the natural griselimycin

• Case study in peptide chemistry
• Modern day optimisation of the natural compound
Griselimycin (GM)
• Novel mode of action and anti-TB properties

Evelyne Fontaine

Evelyne Fontaine, Scientist, Sanofi-Aventis

9:50 CMC case study: Process development, commercial manufacturing and quality control for generic peptide APIs

Daniel Samson

Daniel Samson, Director API Manufacturing, Bachem
View Bio

• Chemical process development, scale-up and large
scale manufacturing of the two generic peptide APIs
Atosiban and Lanreotide
• Analytical control strategy (starting material quality, inprocess
controls, API specifications)
• Comparison of process parameters and drug
substance quality attributes from process performance
qualification and commercial manufacturing

10:30 Morning Coffee

10:50 Development of cytotoxic bicyclic peptide drug conjugates and applications in molecular targeted cancer therapy

• Peptide drug development
• Toxin Conjugate development
• Radio-nuclide conjugates, biodistribution
• Formulation (possibly), physchem etc
• In vitro/vivo results

Dan Teufel

Dan Teufel, Head of Chemistry, Bicycle Therapeutics Limited

11:30 Developing a peptide coagulant and formulation to treat traumatic bleeding

Renata Zbozien

Renata Zbozien, Senior Scientist, Haemostatix Ltd

• Unmet needs in the control of traumatic bleeding
• Design of peptide coagulant and formulation
• Progress to date

12:10 Networking Lunch

13:10 Enhanced drug delivery with Veltis® engineered albumins

Joanna Hay

Joanna Hay, Science Manager, Albumedix

• Short circulatory half-life represents a major obstacle for
many peptide-based therapeutics.
• This can be signifi cantly improved by conjugation or
fusion to albumin, due to increased size and recycling
via the neonatal Fc receptor (FcRn).
• The increased FcRn affi nity of the Veltis® engineered
albumins translates to more than doubling of the already
long half-life of native sequence albumin.
• We will describe rationally engineered albumins and

13:50 Using Cyclotides for oral delivery of biotherapeutics.

Bill Eldridge

Bill Eldridge, CSO, Cyclogenix

• Using Cyclotides for oral delivery of biotherapeutics.
• Bispecific Cyclotides as a new class of Immuno-oncology agents.

14:30 Afternoon Tea

14:50 Strategies for peptide-based vaccines development for antiviral diseases

Elisabetta Bianchi

Elisabetta Bianchi, Head of Peptide Chemistry , IRBM Science Park

• Identification of potentially protective epitopes
• Design and conjugation of conformationally constrained epitopes
• Strategies to enhance immunogenicity

15:30 Vaccination via the oral route

Roger New

Roger New, Director, R&D, Proxima Concepts Ltd

• Strategies for delivery to Peyer’s Patches
• Deployment of sub-unit vaccines
• Success in challenge models

16:10 Chairman’s Closing Remarks and Close of Day Two

Dan Teufel

Dan Teufel, Head of Chemistry, Bicycle Therapeutics Limited



Dan Teufel

Dan Teufel

Head of Chemistry, Bicycle Therapeutics Limited
Daniel Samson

Daniel Samson

Director API Manufacturing, Bachem
Evelyne Fontaine

Evelyne Fontaine

Scientist, Sanofi-Aventis
Leila Narimen Beniddir

Leila Narimen Beniddir

Study Manager/Scientist- Novel Drug Delivery Technologies, Ipsen
Lutz Jermutus

Lutz Jermutus

Senior Director, R&D, MedImmune

Ashok Bhandari

VP, Chemistry, Protagonist Therapeutics
Ashok Bhandari

Bill Eldridge

CSO, Cyclogenix
Bill Eldridge

Dan Teufel

Head of Chemistry, Bicycle Therapeutics Limited
Dan Teufel

Daniel Samson

Director API Manufacturing, Bachem
Daniel Samson

After obtaining his PhD in organic chemistry Daniel joined Bachem's peptide manufacturing headquarters in Switzerland in 2007. As a team leader he has been responsible for the synthesis of peptides and small proteins. From 2009 to 2011 he held a lab head position focusing on process optimization, technology transfer and scale-up of synthetic peptide manufacturing procedures. In 2010 Daniel joined Bachem in the United Kingdom temporarily focusing on non-GMP custom syntheses of peptides. From the beginning of 2012 he has been leading Bachem’s cGMP API manufacturing groups back in Switzerland applying large scale SPPS and preparative HPLC. Science 2015 he is a Senior Director and has responsibility for all peptide API manufacturing aspects within Bachem AG.

Elisabetta Bianchi

Head of Peptide Chemistry , IRBM Science Park
Elisabetta Bianchi

Evelyne Fontaine

Scientist, Sanofi-Aventis
Evelyne Fontaine

Gary Bembridge

Director of Scientific Affairs Immunology, Abzena
Gary  Bembridge

Joanna Hay

Science Manager, Albumedix
Joanna Hay

Jonathan Ryves

Director, Cupid Peptides
Jonathan  Ryves

Leila Narimen Beniddir

Study Manager/Scientist- Novel Drug Delivery Technologies, Ipsen
Leila Narimen Beniddir

Lutz Jermutus

Senior Director, R&D, MedImmune
Lutz Jermutus

Mathias Schaffrath

Group Head Chromatography, Sanofi
Mathias  Schaffrath

Oliver Demmer

Innovation Consultant, Innovation Centre Denmark, Ministry Of Foreign Affairs
Oliver Demmer

Renata Zbozien

Senior Scientist, Haemostatix Ltd
Renata Zbozien

Roger New

Director, R&D, Proxima Concepts Ltd
Roger New

Vincent Bille

Founder & Owner, Marble Pharma Consult, sprl
Vincent Bille

Sponsors and Exhibitors

Official Media Partner

Official Publication



Cupid Cell Penetrating Peptides – A Powerful New Tool

Cupid Cell Penetrating Peptides – A Powerful New Tool

Holiday Inn Kensington Forum
5th July 2016
London, United Kingdom

Preliminary list of attendees - 2016


Interview with Renata Zbozien, VP Research, Haemostatix


Sponsors and Exhibitors


Sponsors and Exhibitors

Abzena offers a suite of complementary services and technologies. Its range of technologies include immunogenicity assessment, antibody drug conjugation, protein engineering, PEGylation, cell line development , GMP manufacturing and a range of bespoke assays to enables the development of better biopharmaceuticals which will have a greater chance of reaching the market.


Sponsors and Exhibitors

Bachem provides comprehensive services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based APIs. The group has a global reach with more experience and know-how than any other company in the industry. Bachem. Pioneering Partner for Peptides

Media Partners


Official Media Partner

ecancer is the leading oncology channel committed to improving cancer communication and education with the goal of optimising patient care and outcomes. By using the latest technologies ecancer works closely with leading figures in oncology to inform and educate the global cancer community.

BioChem Adda

Official Media Partner

BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!

WCA Pharma

Official Media Partner

The Members within WCA Pharma all have dedicated personnel fully conversant in the GDP guidelines required for the special handling of Pharmaceutical products. All have the attention to detail required that has seen them become established and recognized by the leading Pharma Industries throughout the world. From Clinical trials, Biotech, Plasma, Laboratory, Health Care, Chilled, Frozen, Controlled Ambient, Packaging, Air, Ocean and Land, you have all Pharmaceutical clusters contained within one exclusive network. Our members are able to pass on their knowledge to clients and use their skills, trust and experience in ensuring all products arrive on time and in the perfect condition. Making sure products are shipped via the correct method, temperature, atmosphere and under controlled conditions ensures these valuable shipments have the care and attention whilst being handled that they deserve.

The Pharma Letter

Official Media Partner

The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.

Media Partners

International Journal of Biomedical Engineering and Technology

Official Publication

IJBET addresses cutting-edge research in the multi-disciplinary area of biomedical engineering and technology. Medical science incorporates scientific/technological advances combining to produce more accurate diagnoses, effective treatments with fewer side effects, and improved ability to prevent disease and provide superior-quality healthcare. A key field here is biomedical engineering/technology, offering a synthesis of physical, chemical, mathematical and computational sciences combined with engineering principles to enhance R&D in biology, medicine, behaviour, and health. IJBET includes the Asia-Pacific Chapter in Biomedical Wireless Technology (APC-BWT).

International Journal of Healthcare Technology and Management

Official Publication

IJHTM is a series emerging from the International Journal of Technology Management. It provides an international forum and refereed authoritative sources of information in the fields of the economics and management of technology in healthcare.

Int. J. of Immunological Studies

Official Publication

IJIS publishes a broad range of papers on all aspects of immunology from scientists in academic and non-academic organisations as well as business and government worldwide. IJIS is the flagship journal of the Frontiers in Immunology Research Network.

International Journal of Computational Biology and Drug Design

Official Publication

IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.

International Journal of Biotechnology

Official Publication

IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.

Media Partners

Drug Target Review


Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.

Swiss Biotech Association


The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.

Antibodies Online


antibodies-online.com facilitates researchers to find the appropriate antibodies for their respective research project. As an independent and multi-vendor marketplace for research antibodies and thanks to the cooperation with more than 130 different manufacturers, a large selection of Antibodies (over 700,000), ELISA Kits (over 130,000), Secondary Antibodies (17,000), Proteins (130,000), Peptides and Isotype Controls is available. By supporting the Independent Validation Initiative and the Resource Identification Initiative, antibodies-online.com also addresses the important topics of transparent product quality and scientific reproducibility. In addition scientists receive news and detailed information about the individual antibodies from databases such as the PubMed and others.



Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/



pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com

Drug Discovery Today


Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.

Medical News Today


Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.

Lab Bulletin


Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information. Lab Bulletin also publishes four free monthly E-Newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated E-Newsletters for Chromatography and Spectroscopy, Microscopy and Image Analysis, weekly Industry News updates and our monthly Lab Bulletin E-Newsletter sent out to over 29,000 readers worldwide. To request your free copy click here



Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.



Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.



Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.



Labiotech.eu is the leading digital media covering the European Biotech industry. Over 100,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you'll enjoy reading our stories!



GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.



CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.



Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!





PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.

Bentham Science


Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/. Bentham is offering attendees of this conference discounts on its publication. For more information click here



FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!

Contract Biotechnology


Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. It is an online R&D matching tool that connects Scientifics and service and product providers worldwide. The platform Contract-Biotechnology.com would help you in the process of finding the right partner saving time and money, because with one single and secure application you would be able to receive multiple quotes quickly, keeping your contact information confidential. Contract-Biotechnology.com is the new Collaboration Network Model for Discovery Research and Development. Contract-Biotechnology.com team has extensive experience working for pharmaceuticals, biotechs, universities and academic research institutes and can help you addressing your key gaps.

International Pharmaceutical Industry


IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.

Chimica Oggi – Chemistry Today


Chimica Oggi – Chemistry Today, the international journal of Fine Chemicals, Applied Chemistry and Biotechnology, is a peer reviewed, bimonthly journal, specialized in fine chemistry, pharmaceuticals, analytical technologies, chemical engineering and biotechnology of the TKS – TeknoScienze Publisher. Founded in 1983 Chimica Oggi – Chemistry Today soon became a leading journal in linking industry and academia and gained an immediate appreciation.

British Pharmacological Society


The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.

Select Science


SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.

Technology Networks


Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com

WCA Time Critical




MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com

Drug Discovery World


For over a decade DDW has continued to be the ‘must read’ journal within the DD&D Arena. DDW is recognised for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised platform for Industry Gurus to debate some of the more challenging technological and business issues facing the the life science industry. DDW adheres to the maxim..... ‘Turning Science into Business’ DDW examines the advances in new technologies and the associated implications within the context of developing new and efficacious therapeutics. DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level, allowing both camps to profit from the uncomplicated style of editorial but at the same time challenges our readers to look at new ways to overcome discovery bottlenecks, embrace nascent technologies and build next generation technology platforms.



The complete and transparent marketplace for your research antibodies, kits, proteins and small molecules. The sophisticated search engine, with more than 800.000 products, transparency in suppliers, easy comparison, the one stop shop for your research antibodies in combination with interesting news and events plus a CMO exchange makes us a full service partner for you.

Holiday Inn Kensington Forum

97 Cromwell Road
London SW7 4DN
United Kingdom

Holiday Inn Kensington Forum

Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 



speaker image






CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

Event Title


Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event


Sign up
Forgotten Password?

Contact SAE Media Group

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smgconferences.com Email: events@saemediagroup.com
Registered in England - SMi Group Ltd trading as SAE Media Group

Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SAE Media Group.
Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out